“What are the possible reasons for the rejection of an ethical approval application, and what steps can researchers take to address the concerns raised? Can the application be revised and resubmitted, and if so, what is the typical process ...
Research Mitra Latest Questions
“Who is responsible for registering a clinical trial in CTRI—principal investigator, sponsor, or institution—and what are the key steps in the registration process?”
“Why is it important to register clinical trials in CTRI, and how does it enhance transparency, accountability, and compliance with ethical and regulatory standards?”
“What is the Clinical Trials Registry – India (CTRI), and how does it facilitate the registration, transparency, and ethical oversight of clinical trials in India?”
“What types of clinical studies must be registered in CTRI, including interventional trials, observational studies, bioavailability studies, and post-marketing surveillance?”
“What is the usual timeline for obtaining ethical approval, and what factors influence the duration, such as the complexity of the study, review frequency of the ethics committee, and the need for revisions or resubmissions?”
“Is additional ethical approval required for modifications to the research design after initial approval, and what is the process for submitting amendments to the ethics committee?”
“Who is responsible for reviewing ethical approval applications—an institutional review board (IRB), ethics committee, or regulatory body—and what criteria do they assess?”
“What are a researcher’s responsibilities in reporting adverse events, including timelines, documentation, and communication with the ethics committee and relevant authorities?”